Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Operating Leases (2018 - 2025)

Cellectis has reported Operating Leases over the past 8 years, most recently at $27.7 million for Q4 2025.

  • Quarterly results put Operating Leases at $27.7 million for Q4 2025, down 19.04% from a year ago — trailing twelve months through Dec 2025 was $27.7 million (down 19.04% YoY), and the annual figure for FY2025 was $27.7 million, down 19.04%.
  • Operating Leases for Q4 2025 was $27.7 million at Cellectis, down from $34.2 million in the prior quarter.
  • Over the last five years, Operating Leases for CLLS hit a ceiling of $71.5 million in Q4 2021 and a floor of $27.7 million in Q4 2025.
  • Median Operating Leases over the past 5 years was $42.9 million (2023), compared with a mean of $45.2 million.
  • Biggest five-year swings in Operating Leases: fell 5.59% in 2021 and later tumbled 30.99% in 2022.
  • Cellectis' Operating Leases stood at $71.5 million in 2021, then plummeted by 30.99% to $49.4 million in 2022, then fell by 12.99% to $42.9 million in 2023, then dropped by 20.26% to $34.2 million in 2024, then dropped by 19.04% to $27.7 million in 2025.
  • The last three reported values for Operating Leases were $27.7 million (Q4 2025), $34.2 million (Q4 2024), and $42.9 million (Q4 2023) per Business Quant data.